GMED vs IDXX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jun 25, 2026

GMED

60.4
AI Score
VS
GMED Wins

IDXX

55.5
AI Score

Investment Advisor Scores

GMED

60score
Recommendation
BUY

IDXX

56score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GMED IDXX Winner
Forward P/E 17.6367 36.7647 GMED
PEG Ratio 1.7253 3.4687 GMED
Revenue Growth 27.0% 14.3% GMED
Earnings Growth 66.7% 17.2% GMED
Tradestie Score 60.4/100 55.5/100 GMED
Profit Margin 18.9% 24.6% IDXX
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD GMED

Frequently Asked Questions

Based on our detailed analysis, GMED is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.